Clinical Trials · NCT04103034
A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Band Therapeutics
- Enrollment
- 112
- Start date
- Oct 2019
- Locations
- 1 site, Austria
- Primary endpoint
- Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0